AtaiBeckley Inc.
ATAINASDAQHealthcareBiotechnology
As of Sep 11, 2026 close
- Market cap
- $2.65B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- 91.84%
- 52-week range
- $3.27$7.45
- Volume (live)
- -
- Avg. volume (3M)
- 14.33M
AtaiBeckley (ATAI) Stock Price & Financial Analysis
AtaiBeckley Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.35 - $7.35 |
|---|---|
| 52-Week High | $7.45 |
| 52-Week Low | $3.27 |
| Open | $7.35 |
| Average Volume (3M) | 14.33M |
| Revenue (TTM) | 4.47M |
|---|---|
| Net Income (TTM) | -668.19M |
| Free Cash Flow (TTM) | -137.70M |
| EPS (TTM) | −$2.39 |
| Profit Margin | -14938.37% |
| Operating Margin | -3138.45% |
| Return on Equity (ROE) | -378.71% |
| Debt to Equity | 0.01 |
| Annual Dividend | $6.75 |
|---|---|
| Dividend Yield | 91.84% |
| Last Dividend Ex-Date | Sep 9, 2026 |
| Market Cap | 2.65B |
|---|---|
| Shares Outstanding | 360.75M |
| Price to Sales (P/S) | 592.79 |
| Price to Book (P/B) | 15.03 |
| EV/EBITDA | -3.72 |
| 50-Day MA | $6.90 |
|---|---|
| 200-Day MA | $4.74 |
| 1-Year Change | +13.95% |
Source: Market prices and company fundamentals. Data as of Sep 11, 2026. Data sources and methodology
AtaiBeckley at a Glance
As of the Sep 11, 2026 close, AtaiBeckley (ATAI) has a market capitalization of $2.65B. The stock trades at 592.8× sales. Over the trailing twelve months it lost $668.19M on revenue of $4.47M and burned $137.70M of free cash flow. Revenue grew 93.7% year over year.
As of its latest reported balance sheet, it holds $168.81M in cash and securities against $1.57M of debt, a net cash position of $167.24M.
AtaiBeckley pays dividends totaling $6.75 per share a year, a 91.84% yield at the Sep 11, 2026 close.
The share price is up 14.0% over the past year. At $7.35 (the Sep 11, 2026 close) it sits near the top of its 52-week range of $3.27 to $7.45, above its 200-day moving average of $4.74.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About AtaiBeckley
What is the current stock price for ATAI?
As of the Sep 11, 2026 close, ATAI stock trades at $7.35. The 52-week range is $3.27–$7.45, with a day range of $7.35–$7.35.
What is the P/E ratio for ATAI?
The P/E ratio (Price-to-Earnings) for ATAI is shown in the Key Statistics section. This valuation metric helps compare AtaiBeckley Inc. to industry peers.
Does ATAI pay dividends?
Yes, AtaiBeckley pays a 91.84% annual dividend yield as of the Sep 11, 2026 close ($6.75 per share a year). The most recent ex-dividend date was September 9, 2026.
What do analysts recommend for ATAI?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for ATAI is Buy.
What is the market cap of ATAI?
As of the Sep 11, 2026 close, AtaiBeckley's market capitalization is $2.65B, classifying it as a mid-cap company. AtaiBeckley operates in the Healthcare sector within the Biotechnology industry.